Having observed first hand the immense potential of naturally inspired molecules while building two successful biotech companies in this space, we decided to build an engine to launch such medicine development programs at scale. The plant, the fungal and the animal kingdoms have co-evolved over hundreds of millions of years yielding innumerable symbiotic relationships at the molecular and protein level that are waiting to be discovered and adapted for the development of human medicines. This strategy should significantly improve the odds in drug development to successfully bring novel medications to patients in need.

​Lars Wilde

CEO and Founder Pangea Botanica